StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) stock

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.15−0.39 (-4.57%)

Close on Nov 17, 2026Market cap $284.29MP/E –Yield –

Benitec Biopharma total assets

Total assets on the balance sheet at the end of each period.

Benitec Biopharma's total assets was $182.62M at Jun 30, 2026. For fiscal 2026 it was $182.62M, up 83.4% from the year before. The highest annual figure on record is $182.62M in fiscal 2026.

Annual total assets

PeriodPeriod endValueChange
FY2026Jun 30, 2026$182.62M+83.4%
FY2025Jun 30, 2025$99.59M+90.8%
FY2024Jun 30, 2024$52.21M+1069.6%
FY2023Jun 30, 2023$4.46M-25.3%
FY2022Jun 30, 2022$5.97M-72.1%
FY2021Jun 30, 2021$21.38M+84.5%
FY2020Jun 30, 2020$11.59M-39.8%
FY2019Jun 30, 2019$19.24M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026$182.62M+83.4%
Q3 FY2026CQ1 2026Mar 31, 2026$187.00M+77.7%
Q2 FY2026CQ4 2025Dec 31, 2025$190.68M+141.2%
Q1 FY2026CQ3 2025Sep 30, 2025$96.03M+39.6%
Q4 FY2025CQ2 2025Jun 30, 2025$99.59M+90.8%
Q3 FY2025CQ1 2025Mar 31, 2025$105.21M+601.4%
Q2 FY2025CQ4 2024Dec 31, 2024$79.07M+270.3%
Q1 FY2025CQ3 2024Sep 30, 2024$68.77M+154.2%
Q4 FY2024CQ2 2024Jun 30, 2024$52.21M+1069.6%
Q3 FY2024CQ1 2024Mar 31, 2024$15.00M+82.5%
Q2 FY2024CQ4 2023Dec 31, 2023$21.35M+79.4%
Q1 FY2024CQ3 2023Sep 30, 2023$27.05M+49.3%
Q4 FY2023CQ2 2023Jun 30, 2023$4.46M-25.3%
Q3 FY2023CQ1 2023Mar 31, 2023$8.22M-18.3%
Q2 FY2023CQ4 2022Dec 31, 2022$11.91M-15.0%
Q1 FY2023CQ3 2022Sep 30, 2022$18.12M+1.6%
Q4 FY2022CQ2 2022Jun 30, 2022$5.97M-72.1%
Q3 FY2022CQ1 2022Mar 31, 2022$10.06M-25.1%
Q2 FY2022CQ4 2021Dec 31, 2021$14.01M-9.7%
Q1 FY2022CQ3 2021Sep 30, 2021$17.84M+100.0%
Q4 FY2021CQ2 2021Jun 30, 2021$21.38M+84.5%
Q3 FY2021CQ1 2021Mar 31, 2021$13.43M-30.2%
Q2 FY2021CQ4 2020Dec 31, 2020$15.51M–
Q1 FY2021CQ3 2020Sep 30, 2020$8.92M–
Q4 FY2020CQ2 2020Jun 30, 2020$11.59M–
Q4 FY2019CQ2 2019Jun 30, 2019$19.24M–

More Benitec Biopharma figures

See a number that looks wrong?